NLRP3-IN-20 (compound 11) is an orally administered inhibitor targeting the NLRP3 inflammasome, exhibiting potent inhibition with an IC50 of 25 nM against IL-1beta secretion. It possesses excellent pharmacokinetic properties and has shown significant effica
Molekulargewicht:
413.53
CAS Nummer:
[2428478-22-0]
Formel:
C22H27N3O3S
Target-Kategorie:
NOD-like Receptor (NLR)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten